Literature DB >> 29626421

Characterisation of peroxidasin activity in isolated extracellular matrix and direct detection of hypobromous acid formation.

Boushra Bathish1, Rufus Turner1, Martina Paumann-Page1, Anthony J Kettle1, Christine C Winterbourn2.   

Abstract

Peroxidasin is a heme peroxidase that catalyses the oxidation of bromide by hydrogen peroxide to form an essential sulfilimine cross-link between methionine and hydroxylysine residues in collagen IV. We investigated cross-linking by peroxidasin embedded in extracellular matrix isolated from cultured epithelial cells and its sensitivity to alternative substrates and peroxidase inhibitors. Peroxidasin showed peroxidase activity as measured with hydrogen peroxide and Amplex red. Using a specific mass spectrometry assay that measures NADH bromohydrin, we showed definitively that the enzyme releases hypobromous acid (HOBr). Less than 1 μM of the added hydrogen peroxide was used by peroxidasin. The remainder was consumed by catalase activity that was associated with the matrix. Results from NADH bromohydrin measurements indicates that low micromolar HOBr generated by peroxidasin was sufficient for maximum sulfilimine cross-linking, whereas 100 μM reagent HOBr or taurine bromamine was less efficient. This implies selectivity for the enzymatic process. Physiological concentrations of thiocyanate and urate partially inhibited cross-link formation. 4-Aminobenzoic acid hydrazide, a commonly used myeloperoxidase inhibitor, also inhibited peroxidasin, whereas acetaminophen and a 2-thioxanthine were much less effective. In conclusion, HOBr is produced by peroxidasin in the extracellular matrix. It appears to be directed at the site of collagen IV sulfilimine formation but the released HOBr may also undergo other reactions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Collagen IV cross-linking; Heme peroxidases; Hypobromous acid; Peroxidasin; Sulfilimine cross-link

Mesh:

Substances:

Year:  2018        PMID: 29626421     DOI: 10.1016/j.abb.2018.03.038

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Peroxidasin-mediated bromine enrichment of basement membranes.

Authors:  Cuiwen He; Wenxin Song; Thomas A Weston; Caitlyn Tran; Ira Kurtz; Jonathan E Zuckerman; Paul Guagliardo; Jeffrey H Miner; Sergey V Ivanov; Jeremy Bougoure; Billy G Hudson; Selene Colon; Paul A Voziyan; Gautam Bhave; Loren G Fong; Stephen G Young; Haibo Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

2.  Air pollution particles hijack peroxidasin to disrupt immunosurveillance and promote lung cancer.

Authors:  Zhenzhen Wang; Ziyu Zhai; Chunyu Chen; Xuejiao Tian; Zhen Xing; Panfei Xing; Yushun Yang; Junfeng Zhang; Chunming Wang; Lei Dong
Journal:  Elife       Date:  2022-04-19       Impact factor: 8.140

3.  Measuring peroxidasin activity in live cells using bromide addition for signal amplification.

Authors:  Veronika F S Pape; Hajnal A Kovács; István Szatmári; Imre Ugrai; Bence Szikora; Imre Kacskovics; Zoltán May; Norbert Szoboszlai; Gábor Sirokmány; Miklós Geiszt
Journal:  Redox Biol       Date:  2022-06-30       Impact factor: 10.787

4.  Uric Acid Reacts with Peroxidasin, Decreases Collagen IV Crosslink, Impairs Human Endothelial Cell Migration and Adhesion.

Authors:  Bianca Dempsey; Litiele Cezar Cruz; Marcela Franco Mineiro; Railmara Pereira da Silva; Flavia Carla Meotti
Journal:  Antioxidants (Basel)       Date:  2022-06-04

5.  Peroxidasin mediates bromination of tyrosine residues in the extracellular matrix.

Authors:  Boushra Bathish; Martina Paumann-Page; Louise N Paton; Anthony J Kettle; Christine C Winterbourn
Journal:  J Biol Chem       Date:  2020-07-16       Impact factor: 5.157

6.  The skeletome of the red coral Corallium rubrum indicates an independent evolution of biomineralization process in octocorals.

Authors:  Nathalie Le Roy; Philippe Ganot; Manuel Aranda; Denis Allemand; Sylvie Tambutté
Journal:  BMC Ecol Evol       Date:  2021-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.